About Cystinuria.org

This author has not yet filled in any details.
So far Cystinuria.org has created 74 blog entries.

Helen’s Story

By |2021-06-17T16:47:17-07:00June 16th, 2021|

Helen's Story Helen Guerra, a 20-year-old resident of Miami, has lived more than half of her young life diagnosed with a rare kidney disease called cystinuria. She led a fulfilling childhood filled with a love for reading, dancing, and all things Disney. Helen’s life changed at age 9, however, when she began experiencing [...]

Sierra Gibbs

By |2021-06-18T08:59:25-07:00June 16th, 2021|

Sierra Gibbs Sierra Gibbs is a sophomore at California State University, Long Beach. Her life may seem like everybody else’s around her, but her story is not.  At 13, while growing up in Colfax, CA, she was diagnosed with Cystinuria, an incurable, rare and debilitating disease she knew nothing about.  “It’s hard to look [...]

Michael’s Story

By |2021-06-15T08:10:40-07:00June 14th, 2021|

A Patient's Story: Michael Eckstut (New Jersey) Skillman resident Michael Eckstut, 69, enjoys a full and rewarding life in his roles as a husband, a father to three grown children, and a successful executive at a pharmaceutical services company. Although you wouldn’t know it judging by his active lifestyle and positive outlook, Michael has [...]

Leah’s Story

By |2021-06-14T10:11:58-07:00June 14th, 2021|

Leah's Story - Life with Cystinuria Leah, a 42-year-old resident of Montgomery, Michigan, has struggled with kidney problems from the incredibly young age of 2. Her journey of uncovering the truth behind these medical issues would take 40 years of incorrect diagnoses, six different urologists, losing her right kidney, and immense pain that made [...]

Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets

By |2021-06-14T10:05:47-07:00May 18th, 2021|

Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first available generic version, in the U.S., of THIOLA® (tiopronin) tablets, indicated, [...]

α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases

By |2021-06-14T10:05:47-07:00March 26th, 2021|

α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases Cystinuria is an autosomal recessive disorder characterized by excessive urinary excretion of cystine, resulting in recurrent cystine kidney stones, often presenting in childhood. Current treatment options for cystinuria include dietary and/or fluid measures and potassium citrate to reduce cystine excretion and/or [...]

Go to Top